Format

Send to

Choose Destination
Public Health Rep. 2016 Jan-Feb;131 Suppl 1:139-46.

Pharmacy Intervention to Improve HIV Testing Uptake Using a Comprehensive Health Screening Approach.

Author information

1
Emory University, Rollins School of Public Health, Behavioral Sciences and Health Education, Atlanta, GA.
2
Jaeb Center for Health Research, Tampa, FL.
3
Columbia University, Mailman School of Public Health, Department of Epidemiology, New York, NY.
4
Columbia University, Mailman School of Public Health, Department of Population and Family Health, New York, NY; Columbia University, College of Physicians and Surgeons, Center for Family and Community Medicine, New York, NY.
5
The Calverton Center, Pacific Institute for Research and Evaluation, Calverton, MD.
6
Nathan Kline Institute for Psychiatric Research, Division of Social Solutions and Services Research, Orangeburg, NY; New York University, School of Medicine, Department of Psychiatry, New York, NY.

Abstract

OBJECTIVE:

HIV testing is increasingly available, yet barriers to HIV testing persist for low-income black and Latino people, especially those who use illicit drugs. HIV exceptionalism, or the idea that a positive HIV diagnosis is drastically different from a diagnosis for any other disease, may influence HIV testing-related stigma, resulting in reduced willingness to undergo HIV testing. This pharmacy-based intervention combined HIV testing with less stigmatized chronic disease screening tests (e.g., blood pressure, glucose, and cholesterol) to equate the concept of an HIV diagnosis with other diagnoses.

METHODS:

Three pharmacies located in low-income, minority neighborhoods in New York City were enrolled in an intervention to provide (1) HIV testing, chronic disease screening, and a healthy lifestyles video that normalized all screening tests and destigmatized HIV as a fatal disease (comprehensive arm); (2) HIV testing and the video (video arm); and (3) HIV testing only (control arm). Injection drug users (IDUs) and pharmacy staff recruited un- and underinsured pharmacy customers, IDUs, and IDU peers from 2010 to 2012. Participants in the control group were compared with those in the comprehensive and video intervention groups.

RESULTS:

Participants in the comprehensive arm (prevalence ratio [PR] = 1.61, 95% confidence interval [CI] 1.03, 2.49, p=0.08) and the video arm (PR=1.59, 95% CI 1.00, 2.53, p=0.09) were marginally significantly more likely to receive an HIV test in the pharmacy compared with those in the control arm after adjustment.

CONCLUSIONS:

These findings suggest that adoption of strategies that destigmatize and normalize HIV testing can improve uptake. Implementation of this strategy in low-access, minority communities with high HIV prevalence and among high-risk populations may help reduce racial/ethnic disparities in HIV.

PMID:
26862239
PMCID:
PMC4720615
DOI:
10.1177/00333549161310S116
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center